Akitoshi Yanagihara1, Satoshi Yamasaki2, 3, Kosuke Hashimoto2, Ryo Taguchi1, Tetsuya Umesaki1, Hisao Imai2, Kyoichi Kaira2, Hiroyuki Nitanda1, Hirozo Sakaguchi1, et al. A Th1-like CD4+ T-cell Cluster that Predicts Disease-free Survival in Early-Stage Lung Cancer. Cancer research communications. 2023. 3. 7. 1277-1285
Kagamu, H., S. Kitano, O. Yamaguchi, K. Yoshimura, K. Horimoto, M. Kitazawa, K. Fukui, A. Shiono, A. Mouri, et al. CD4(+) T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy. Cancer Immunology Research. 2019. 8. 3. 334-344
Kaira, K. Kagamu, H. Drastic Response of Re-challenge of EGFR-TKIs Immediately After Nivolumab Therapy in EGFR-TKI-Resistant Patients. Journal of Thoracic Oncology. 2019. 14. 6. e135-3136
Hideki Onishi, Mayumi Ishida, Hiroshi Kagamu, Yoshitake Murayama, Kunihiko Kobayashi, Izumi Sato, Nozomu Uchida, Tatsuo Akechi. Wernicke encephalopathy in a lung cancer patient during treatment with nivolumab. Palliative & supportive care. 2018. 1-3
Single cell解析による末梢血と腫瘍微小免疫環境の相関
(第81回日本癌学会学術総会 2022)
Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future prospective - oral presentation -
(33rd European Congress of Pathology (Virchows Archiv) 2021)
